Recent advances in monoclonal antibody therapies targeting A plaques (e.g., donanemab, lecanemab) have shown potential, but they also pose significant risks, such as amyloid-related imaging abnormalities with edema (ARIA-E), highlighting the need for safer and more effective alternatives
As wildly popular as these drugs already are (I know a woman who inflated her weight dramatically to get a prescription from an online provider), expect to see their use skyrocket now that theres a no-jab option
This evidence-based guide breaks down the top peptides for performance and recovery, Read More GLP-1s, Peptides, and the Miami Weight Loss Revolution The Weight Loss Paradigm Shift Five years ago, if you mentioned the words weight loss to a cardiologist, theyd probably talk about heart-healthy diets, exercise routines, and behavior modification
Sobo Tirzepatide Dr